Peter Iglauer

Differential expression and dendritic transcript localization of Shank family members: identification of a dendritic targeting element in the 3′ untranslated region of Shank1 mRNA

J. Bockmann, M. Kreutz, E. Gundelfinger, 2004, Molecular and Cellular Neuroscience.

Shank1 mRNA: Dendritic Transport by Kinesin and Translational Control by the 5′Untranslated Region

F. Wouters, M. Kneussel, D. Richter, 2009, Traffic.

Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib.

M. Tiemann, G. Sauter, C. Bokemeyer, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Sarcomatoid Adrenal Carcinoma: Case Report with Contribution to Pathogenesis

W. Wilczak, W. Saeger, M. Behrend, 2017, Endocrine Pathology.

Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report

C. Bokemeyer, R. Simon, S. Loges, 2021, Oncology Research and Treatment.

Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations

U. Schüller, A. Giese, C. Mawrin, 2021, Acta Neuropathologica.

Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells

N. Stoecklein, S. Riethdorf, S. Peine, 2024, Molecular cancer.